Available via license: CC BY-NC 4.0
Content may be subject to copyright.
Abstract
A functional intestinal Flora, physiologically speaking, is an
important indication of a healthy organism; therefore, it is an
important ally for the Function of Defense. The study was con-
ducted on an adult population from January 2012 to June 2013. 34
individuals were considered, regardless of age and sex, of which
23 females (67.6%) and 11 males (32.4%), aged between 27 and
62 (average: 43.9 years). For the evaluation of abdominal pres-
sure-like pain and discomfort caused by other typical disorders of
dysbiosis, a visual-analogue scale was chosen, according to the
Scott and Huskisson model.
The results of the study made it possible to verify - first of all
- that intestinal dysbiosis is a disease with a higher incidence with
respect to what clinical data does not allow to establish on the
basis of subjective and objective symptoms.
In conclusion, the study confirmed the validity of the treat-
ment with ozonized water combined with rectal insufflation of
oxygen and ozone mixture.
Introduction and Definition
A functional intestinal Flora, physiologically speaking, is an
important indication of a healthy organism; in fact, it is estab-
lished that normal Microflora is not only the first barrier to infec-
tions, but it also has other functions that help maintain good
human health.1
Therefore, it is an important ally for the Function of Defense,
antagonistic in regard to pathogenic germs and harmful bacteria
thanks to the production of natural antibiotics and bacteriocins.2
When physiological Flora is balanced and in symbiosis with
the organism it becomes beneficial for both, and is referred to as
Eubiosis.3
When, for various reasons, which we will get to later, there is
an alteration of the microbial ecosystem with a disruption and
gradual alteration of the normal microbial flora, then we are deal-
ing with Dysbiosis.
More precisely it is known as intestinal dysbiosis, referring to
a set of symptoms and functional gastrointestinal disorders that
can evolve into diseases involving organs or systems distant from
the colon, through microbial lymphogenous propagation with the
blocking of MALT and GALT.4
It represents, in fact, a very common social problem, caused
by the functional alteration of the colonic mucosa and the modifi-
cation of the intestinal bacterial flora, with consequent alteration
of the composition of the bacterial flora residing in the intestine.
If we consider the vast surface of the gastro-intestinal mucosa
and its grand capacity for absorption, we can comprehend that an
alteration of intestinal conditions generates many toxic substances
(toxins), which, after being circulated through the blood and lym-
phatic pathways, are distributed in various parts of the body creat-
ing multiple dysfunctions and pathologies.
Following are some of the main symptoms of dysbiosis: poor
digestion, swelling, constipation alternating with dysentery, fecal
mucus, mood changes, sleep disturbances, vaginal candidiasis,
dysmenorrhea, asthenia, halitosis, headaches, allergies, etc.5
The diagnosis of intestinal dysbiosis is made through:
Medical history: recently taken medication, diet, smoking,
work environment, lifestyle etc.
Symptoms: flatulence, constipation and/or diarrhea, chronic
gingivitis, meteorism, chronic asthenia, food intolerances up to
actual allergies in general, chronic gastritis, headaches, etc.
Laboratory data: alterations of transaminases and alpha-amy-
lases, coproculture, fecal pH (in the case of normal intestinal flora
the pH of the large intestine corresponds to a value between 5.5
and 6.0 from childhood to adulthood. Values above pH 6.0 are
already suspicious); indole test in urine samples (in urine there are
normally small amounts of indole equal to 4-20 mg in the 24
hours). In case of severe intestinal dysbiosis, skatole is present in
the urine as well.
Regarding the therapeutic approach to the pathology, we must
remember that the complexity of the pathogenetic and pathophys-
iological phenomena that characterize the dysbiotic phenomenon
must inevitably provide, from a therapeutic point of view, an inte-
grated intervention that aims, on the one hand, to act on the host
and on the other, to the homeostatic rebalancing of the intestinal
microclimate, restoring the balance between the different bacterial
species.
Correspondence: Fortunato Loprete and Francesco Vaiano, Oxygen-
Ozone Therapy Scientific Society (SIOOT), via Roma 69, 24020 Gorle
(BG), Italy.
E-mail: dottf.loprete@gmail.com ; francescovaiano@fastwebnet.it
Key words: Ozonated water; rectal insufflation; intestinal dysbiosis.
Received for publication: 23 December 2017.
Accepted for publication: 28 December 2017.
©Copyright F. Loprete and F. Vaiano, 2017
Licensee PAGEPress, Italy
Ozone Therapy 2017; 2:7304
doi:10.4081/ozone.2017.7304
This article is distributed under the terms of the Creative Commons
Attribution Noncommercial License (by-nc 4.0) which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
The use of ozonated water and rectal insufflation in patients
with intestinal dysbiosis
Fortunato Loprete,1Francesco Vaiano2
1Private practitioner, Surgeon, Padova; 2Private practitioner, Surgeon, Desio (MB), Italy
[page 56] [Ozone Therapy 2017; 2:7304]
Ozone Therapy 2017; volume 2:7304
Non-commercial use only
Therefore, it is of fundamental importance to restore a correct
balance of bacterial flora, through an appropriate combined treat-
ment aimed both at the drainage of the gastrointestinal system and
its functionally related organs (liver, pancreas, etc.), and at prepar-
ing the colon for the subsequent treatment of recolonization using
an oxygen-ozone mixture and probiotics.
Ozone therapy (by means of rectal insufflation and especially
by means of hyperozonated water administered orally) has proved
to be, in recent years, a medical treatment with vast application
possibilities. Its effectiveness has been demonstrated in functional
disorders of the colon and in the rehabilitation of the peristaltic
intestinal capacity.
Patients tolerate this therapy well and it has no short or long-
term side effects. MULTIOSSIGEN ozone therapy by rectal insuf-
flation and hyperozonated water by mouth returns functionality to
the intestine with all the powers for a valid defense against bacte-
ria, viruses and any other toxicity and dysfunction.
Purpose of the study
The goal of the study, which lasted a total of 90 days, was to
verify the effects induced by ozonated water and rectal insufflation
on the overall well being of 34 individuals affected by intestinal
dysbiosis.
The authors show how the mixture of O2-O3represents a valid
aid for the restoration of the physiological status of the altered
mucosa, thus ensuring the digestive and detoxifying functions of
the gastrointestinal tract.
At the beginning, after 45 days and at the end of the study, at
90 days, a certain symptoms (considered the most important ones
by the Authors) were evaluated in the subjects, typical of the
pathology treated (chronic asthenia, meteorism, halitosis, alternate
alveolus (constipation alternating with diarrhea), poor digestion,
gastralgia, irritable bowel, aerophagia and bothersome eructation).
The diagnosis was made by dosing two metabolites, indican
(dosed with colorimetric method) and skatole (with chromato-
graphic method), in samples of biological liquids (urine).
Scientific rationale of ozone therapy
The use of ozone in medicine is dictated by two general con-
siderations; one based on the fact that ozone has direct and indirect
effects on metabolism, and the other on the fact of its biological
effects.6-18
Effects of ozone on metabolisms
- Acceleration of the use of glucose by cells for increased gly-
colysis, which increases the availability of ATP in the cells and
therefore in the tissues, especially nerve related tissue.
- Intervention in protein metabolism due to its affinity with
sulfhydryl groups, thus reacting with essential amino acids such
as methionine and tryptophan or with cysteine containing sulfur.
- Direct reaction with unsaturated fatty acids, which are trans-
formed into water-soluble compounds.
Biological effects of ozone
- In topical application there is disinfection and direct trophic
action.
- For the formation of peroxides, there is a systematic antibac-
terial and antiviral effect. The antiseptic mechanism is similar
to the one that the organism usually uses with the formation, by
the leukocytes used for bacterial phagocytosis, of an antioxi-
dant molecule, similar to that of O3, that is H2O2. The germi-
cidal effect of ozone depends, above all, on the presence of
water and low temperatures. It also has a great capacity to inac-
tivate viruses (virustatic action) making them unable to adhere
with the cell receptors on the target cell and therefore to repli-
cate. If ozone has a virustatic action for viruses, in relation to
bacteria and in particular the gram+presents a bactericidal and
above all direct action.
- At the level of red blood cells, there is an increase in deforma-
bility, reducing the global blood viscosity and increase of 2,3-
diphosphoglycerate (responsible for the transfer of O2from
hemoglobin to tissues), which has, as a final purpose, a marked
improvement in O2transport and therefore a rheological action.
Effects of peroxide products from ozone in phagocytosis
During chronic infections, normal defensive processes are no
longer able to destroy bacteria due to insufficient formation of
H2O2. It is at this level that the positive influence of peroxides
formed during ozone treatment is highlighted.
Influence of ozone in the metabolism of erythrocytes
Peroxide formation facilitates a direct activation of erythrocyte
metabolism. The first step of the reaction consists in the interaction
of ozone with the double bonds of unsaturated fatty acids of the
phospholipid layer in the erythrocyte membrane. With the inter-
vention of the glutathione system, an activation of glycolysis takes
place, which determines an increase of 2,3-diphosphoglycerate,
with relevant ease of release of O2in tissues by the hemoglobin.
Materials and Methods
The study was conducted on an adult population from January
2012 to June 2013. 34 individuals were considered, regardless of
age and sex, of which 23 females (67.6%) and 11 males (32.4%),
aged between 27 and 62 (average: 43.9 years).
The hyperozonated water, produced by means of the OM3
ozone generator (of the company, Multiossigen) was administered
in the quantity of three (3) 125 ml glasses each per day.
Rectal insufflation was carried out 3 times a week; the ozone con-
centration (produced with the Multiossigen Medical 95 device) was
40 µg/ml, while the total amount of the O2-O3mixture was 250 cc per
session, the total ozone concentration administered was 10,000 µg.
All patients were adequately informed on the use of the treat-
ment method for the control of a few classic symptoms of intestinal
dysbiosis and expressed their consent to this type of therapy.
For admission to treatment, adult patients were examined, who
had to meet the following inclusion criteria: adult males and
females (age: 18-70 years) with intestinal dysbiosis, not severe,
confirmed with clinical and instrumental examination, capable of
giving consent to the study after adequate information, able to
guarantee sufficient adherence to the prescribed therapy and moti-
vated to complete the study.
Patient assessment prior to therapy
All patients underwent an initial descriptive pain assessment
and an algometric measurement of the pain threshold, to exclude
subjects with evident chronic pain, through:
Algometric threshold with sphygmomanometer on the dominant
upper limb
The algometric threshold with the sphygmomanometer was
recorded using the following procedure:
- The patient lies down on the examination table, with the cloth-
ing of the lower body removed.
[Ozone Therapy 2017; 2:7304] [page 57]
Article
Non-commercial use only
- The patient is told to relax keeping the upper extremities still,
and the cuff of the sphygmomanometer is wrapped around the
muscles of the dominant arm (triceps and biceps); the patient
is instructed to report when, by inflating the sphygmomanome-
ter, he/she senses pressure that turns into pain, i.e. when it
begins to assume the characteristic of pain.
- The device is pumped every 5 seconds, generating enough air
to increase the pressure by 30 mmHg each time.
- About fifteen strokes are carried out: the first 6-8 in rapid suc-
cession in order to get to 150 mmHg and then at a slower pace
until reaching 300 mmHg, obviously if the patient does not feel
pain before reaching that level.
- When and if the patient feels pain, the operation is interrupted and
the pressure value at which this occurred is recorded in the file.
Post-ischemic stasis test
- With the patient again lying down, the test is carried out on the
dominant arm.
- The patient is informed on what he/she may feel and instructed
not to move any muscle of the upper limb.
- After positioning the sphygmomanometer on the arm, the
patient’s hand is grasped, holding the arm upwards, relaxed, in
order to let the blood flow.
- The sphygmomanometer’s cuff is insufflated up to a 30-40
mmHg pressure higher than the systolic, until no more blood
goes to the arm.
- The arm is positioned horizontally on the examination table and,
without any movement, two minutes are left to pass; in the
meantime, the patient is asked if he/she feels pain. This, howev-
er, should not result in any sensation other than pins and needles.
- After two minutes of ischemia, the sphygmomanometer’s cuff is
deflated to about 80-90 mmHg to create stasis and the stopwatch
is activated, and the patient is requested to say something when
he/she feels pain; normally he/she should not feel pain before 1
minute: i) pain at 1 minute or more = normal threshold; ii) pain
between 30 seconds and 1 minute = moderately low threshold;
iii) pain before 30 seconds = very low threshold.
For the evaluation of abdominal pressure-like pain and dis-
comfort caused by other typical disorders of dysbiosis, a visual-
analogue scale (VAS) was chosen, according to the Scott and
Huskisson model, considered as a subjective measure with a single
dimension, as it only evaluates one component of pain at a time.
The visual analogue scale is the visual representation of the
scope of pain that a patient believes to perceive. The scope may
assume different forms, both as a pain scale and as a pain relief scale.
The answers to the questionnaire may appear to be influenced
by factors that affect the patient’s psychophysical conditions.
The optimal length for measuring the pain appears to be 10 cm.
One extreme indicates the absence of pain, while the other repre-
sents the worst pain imaginable (Figure 1).
The scale was compiled by patients who were asked to indicate
with a mark on the line, to represent the level of pain experienced.
The distance is measured in numerical value, starting from the end
indicating the absence of pain, to represent the extent of the pain
felt, at that moment, by the patient.
VAS scale was proposed to patients undergoing oxygen and
ozone mixture treatment at the beginning of recruitment (before
treatment), after 45 days and at the end of the treatment after 90
days, asking them to mark, on the line between the two extremes,
the extent of the pain or symptoms taken into consideration, com-
pared to the previous assessment.
The fundamental criterion for evaluating treatment efficacy
was the percentage of patients who, at the end of the treatment,
showed a significant reduction in the intensity of the symptoms
taken into consideration, equal to at least 10% of the
baseline value.
The characteristics of the individuals treated are summarized
in Figures 2-5 in time 0, at 45 and 90 days, at the end of the
treatment.
The data, certainly interesting, reflected an apparent and
notable improvement from a statistical point of view regarding
constipation, meteorism, abdominal pains, gastralgia and chronic
asthenia, assessed through the VAS, according to the Scott and
Huskisson model, in individuals treated with a 02-03mixture.
Results and Discussion
All individuals presented a significant improvement, already
by the first assessment, which became considerably more signifi-
cant, from a statistical point of view, by the end of the study.
The results of the study made it possible to verify - first of all
- that intestinal dysbiosis is a disease with a higher incidence with
respect to what clinical data does not allow to establish on the basis
of subjective and objective symptoms.
On the basis of the obtained results, in terms of improvement
of the parameters considered, and the related symptoms, the rectal
insufflation association of the oxygen-ozone mixture with the
intake of hyperozonated water by mouth, has recorded quite
[page 58] [Ozone Therapy 2017; 2:7304]
Article
Figure 1. Visual analogue scale.
Non-commercial use only
encouraging results to such an extent that the authors have con-
cluded that this synergy of approach can be considered as a funda-
mental method in the treatment of intestinal dysbiosis in those
patients resistant to other treatments.
Considering that intestinal dysbiosis is a true pathology
potentially involving the entire Regulatory System, forming the
basis for the multifactorial pathogenesis of many other diseases,
especially of a chronic nature (allergies, immune deficiency dis-
eases, rheumatic diseases, cardiovascular diseases, headaches,
neuroses, etc.), it seems particularly important to carry out a
diagnostic evaluation by assessing the indole and skatole in
urine, for both a preventive purpose, in individuals with appar-
ently good health, and for therapeutic purposes, in patients suf-
fering from chronic diseases of an allergic and/or degenerative
[Ozone Therapy 2017; 2:7304] [page 59]
Article
Figure 2. Characteristics of the individuals treated for constipation, meteorism and abdominal pains in time 0, at 45 days, at the end
of the treatment.
Figure 3. Characteristics of the individuals treated for gastralgia and chronic asthenia time 0, at 45 days, at the end of the treatment.
Non-commercial use only
nature, caused or aggravated by intestinal dysbiosis. This obser-
vational study may be, therefore, a starting point for the develop-
ment of new intervention strategies based on the use of oxygen
and ozone mixture in view of a general improvement of health
conditions in a modern western society, increasingly afflicted by
this pathology that is only the tip of the iceberg of a long series
of symptoms and ailments afflicting it, as it is based on a dietary
lifestyle that is anything but healthy.
Conclusions
In conclusion, the study confirmed the validity of the treatment
with ozonized water combined with rectal insufflation of oxygen
and ozone mixture, to control the symptoms linked to dysbiosis
and to favor the restoration of proper environmental homeostasis at
an intestinal microclimate level in adults.
[page 60] [Ozone Therapy 2017; 2:7304]
Article
Figure 4. Characteristics of the individuals treated for constipation, meteorism and abdominal pains in time 0, at 90 days, at the end
of the treatment.
Figure 5. Characteristics of the individuals treated for gastralgia and chronic asthenia time 0, at 90 days, at the end of the treatment.
Non-commercial use only
References
1. Dethlefsen L, Fall-Ngai M, Relman DA. An ecological and
evolutionary perspective on human-microbe mutualism and
disease. Nature 2007;449:811-8.
2. Lin CS, Chang CJ, Lu CC, et al. Impact of the gut microbiota,
prebiotics, and probiotics on human health and disease.
Biomed J 2014;37:259-68.
3. Reid G, Sanders ME, Gaskins HR, et al. New scientific para-
digms for probiotics and prebiotics. J Clin Gastroenterol 2003;
37:105-18.EARCH
4. Schippa S, Conte MP. Dysbiotic events in gut microbiota:
impact on human health. Nutrients 2014;6:5786-805.
5. Mearin F, Rey E, Balboa A. Motility and functional gastroin-
testinal disorders Gastroenterol Hepatol 2014;37 Suppl 3:3-13.
6. Franzini M. Lezioni presso il Master di 2° livello in
Ossigeno/Ozonoterapia. Pavia: Università di Pavia.
7. Loprete F. Lezioni presso il Master di 2° livello in Ossigeno/
Ozonoterapia. Pavia: Università di Pavia.
8. Rodolico V, Tomasello G. Hsp60 and Hsp10 increase in colon
mucosa of Crohn’s disease and ulcerative colitis. Cell Stress
Chaperones 2010;15:877-84.
9. Montalto M, Santoro L, Curigliano V, et al. Faecal calprotectin
concentrations in untreated coeliac patients. Scand J
Gastroenterol 2007;42:957-61.
10. Vaiano F, Loprete F. Large auto-hemoinfusion versus rectal
insufflation in patients with metabolic syndrome. Gorle (BG):
Oxygen-Ozone Therapy Scientific Society.
11. Bocci V, Zanardi I, Huijberts MS, Travagli V. Diabetes and
chronic oxidative stress. A perspective based on the possible
usefulness of ozone therapy. Siena: University of Siena.
12. Bocci V, Aldinucci C. Biochemical modifications induced in
human blood by oxygenation-ozonation. J Biochem Mol
Toxicol 2006;20:133-8.
13. Bocci V, Luzzi E, Corradeschi F, et al. Studies on the biologi-
cal effects of ozone, 3: an attempt to define conditions for opti-
mal induction of cytokines. Lymph Cytok Res 1993;12:121-6.
14. Shanahan F. Probiotics and inflammatory bowel disease: is
there a scientific rationale. Inflamm Bowel Dis 2000;6:107-15.
15. Porcellini A, Dall’Aglio R, Ubaldi A. Studies on the biological
effects of ozone: induction of tumor necrosis factor (TNF-) on
human leucocytes. Cremona: Dipartimento di Ematologia; 1994.
16. Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal
inflammation targets cancer-inducing activity of the microbio-
ta. Science 2012;338:120-3.
17. Iliev ID, Funari VA, Taylor KD, et al. Interactions between
commensal fungi and the C-type lectin receptor dectin-1 influ-
ence colitis. Science 2012;336:1314-7.
18. Handley SA, Thackray LB, Zhao G, et al. Pathogenic simian
immunodeficiency virus infection is associated with expansion
of the enteric virome. Cell 2012;151:253-66.
[Ozone Therapy 2017; 2:7304] [page 61]
Article
Non-commercial use only